TECENTRIQ HYBREZA J Code: J9024

Drug & Product Overview

HCPCS Descriptor Injection, atezolizumab, 5 mg and hyaluronidase-tqjs

HCPCS Added Date April 1, 2025

Manufacturer Genentech

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection

About TECENTRIQ HYBREZA

Tecentriq Hybreza is a medication aligned to the HCPCS J Code: J9024 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the subcutaneous route and manufactured by Genentech.

According to CMS Drug Use Information: This medication is used to treat various cancers (such as bladder/liver/lung/skin cancer, alveolar soft part sarcoma - ASPS). It contains 2 ingredients: atezolizumab and hyaluronidase. Atezolizumab belongs to a class of drugs known as monoclonal antibodies. It works by helping your immune system fight the cancer. Hyaluronidase is used to help the body absorb atezolizumab, which helps it work better.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
50242-0933-01	Tecentriq Hybreza	Genentech, Inc.	375	1875 MG / 15 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

TECENTRIQ HYBREZA Pricing & Reimbursement

J9024 Private Payer Reimbursement

$32.98 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

TECENTRIQ HYBREZA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 11.43%

Avg. Days to File 5.7days

Avg. Days to Pay 23.8days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9024 claims analytics on FocalPoint →

TECENTRIQ HYBREZA CPT Administration Codes

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

TECENTRIQ HYBREZA Medically Unlikely Edits (MUE)

The most billing units of J9024 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 5 mg.

Practitioner Office & Hospital Outpatient

375 units / day

= 1,875 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

TECENTRIQ HYBREZA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Alveolar Soft Part Sarcoma Extensive-Stage Small Cell Lung Cancer Hepatocellular Carcinoma Melanoma Metastatic Non-Small Cell Lung Cancer Metastatic Non-Squamous Non-Small Cell Lung Cancer Muscle Invasive Bladder Cancer Non-Small Cell Lung Cancer

Drug Class

Antibodies [CS]AntibodiesMonoclonal [CS]MonoclonalHumanized [CS]Endoglycosidase [EPC]Glycoside Hydrolases [CS]Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Frequently Asked Questions

Is there a manufacturer-published TECENTRIQ HYBREZA billing and coding guide?

Billing and coding information for TECENTRIQ HYBREZA can be found through Genentech Inc.. Visit Here →

What are the available TECENTRIQ HYBREZA patient assistance programs?

TECENTRIQ HYBREZA patient assistance information can be found through Genentech Inc.. Visit Here →

Where can I find TECENTRIQ HYBREZA prescribing information?

TECENTRIQ HYBREZA prescribing information can be found at the link below. Visit Here →

Where can I find TECENTRIQ HYBREZA side effect information?

Side effect information for TECENTRIQ HYBREZA can be found at the following source.

Does billing TECENTRIQ HYBREZA require JZ/JW wastage modifiers?

CMS does not include TECENTRIQ HYBREZA (J9024) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9024. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.